Search hospitals
>
Kansas
>
Lawrence
Lawrence Memorial Hospital
Claim this profile
Lawrence, Kansas 66044
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
395 reported clinical trials
23 medical researchers
Summary
Lawrence Memorial Hospital is a medical facility located in Lawrence, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Lawrence Memorial Hospital is involved with conducting 395 clinical trials across 488 conditions. There are 23 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Jun Zhang, Chao H. Huang, and Anwaar Saeed.
Area of expertise
Breast Cancer
Lawrence Memorial Hospital has run 72 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Lawrence Memorial Hospital has run 65 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Shaker Dakhil, M.D.
Ascension Via Christi Hospitals Wichita
7 years of reported clinical research
Jun Zhang
Houston Methodist Hospital
6 years of reported clinical research
Chao H. Huang
University of Kansas Health System Saint Francis Campus
6 years of reported clinical research
Anwaar Saeed
University of Kansas Cancer Center
4 years of reported clinical research
Clinical Trials running at Lawrence Memorial Hospital
Lung Cancer
Bladder Cancer
Breast Cancer
Esophageal cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Breast cancer
Cancer
Pancreatic Cancer
Kidney Cancer
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lawrence Memorial Hospital?
Lawrence Memorial Hospital is a medical facility located in Lawrence, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Lawrence Memorial Hospital is involved with conducting 395 clinical trials across 488 conditions. There are 23 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Jun Zhang, Chao H. Huang, and Anwaar Saeed.
Where is Lawrence Memorial Hospital located?
**Lawrence Memorial Hospital** - **Address:** 325 Maine Street, Lawrence, KS 66044 - **Location:** Approximately 2 miles from downtown Lawrence, near the intersection of Maine Street and 6th Street.
Who should I call to ask about financial aid or insurance network?
**Lawrence Memorial Hospital Financial Assistance** - For financial assistance, including charity care, payment arrangements, and medical assistance programs, please contact our financial counselor at 785-505-5775. - Application forms and further information are available through the financial counselor.
What insurance does Lawrence Memorial Hospital accept?
Lawrence Memorial Hospital accepts Blue Cross and Blue Shield of Kansas (BCBSKS) insurance plans. The hospital participates with most major managed care and governmental health insurance plans in the Northeast, including Medicaid and Medicare. Patients should contact their health insurance company directly to confirm specific plan and benefit coverage, as participation with health plans does not guarantee coverage.
What awards or recognition has Lawrence Memorial Hospital received?
**Lawrence Memorial Hospital, Lawrence, Kansas** - Recognized as one of the 100 Top Hospitals by Truven Health Analytics. - Received a $2 million grant from the Sunderland Foundation for support.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.